UK markets closed

Verona Pharma plc (VRNA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
14.85+0.10 (+0.68%)
At close: 04:00PM EDT
14.85 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close14.75
Open14.70
Bid14.80 x 300
Ask14.87 x 100
Day's range14.70 - 15.11
52-week range11.83 - 23.07
Volume762,317
Avg. volume448,761
Market cap1.15B
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.72
Earnings date01 Aug 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est34.29
  • GuruFocus.com

    Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview

    Insights into Verona Pharma's First Quarter Performance and Future Prospects

  • Insider Monkey

    Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript

    Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript May 9, 2024 Verona Pharma plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to Verona Pharma’s First Quarter 2024 Financial Results and Operating Highlights Conference Call. At […]

  • GlobeNewswire

    Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

    PDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT / 2:00 p.m. BST LONDON and RALEIGH, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical company focused on respiratory diseases, announces its financial results for the first quarter ended March 31, 2024, and prov